Zimbabwe has declined a major American healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years due to Washington's insistence on confidential information.
This move became public after a government memo dated December was disclosed, revealing that Head of State Emmerson Mnangagwa deemed the arrangement was "lopsided".
A government representative later stated that the US was requesting health data for research and profit while refused to guarantee the resulting advantages from any future vaccines.
"We are forced to start the difficult and regrettable task of scaling back our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had provided over $1.9bn for health programmes to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has appealed for further negotiations to reach a agreement acceptable to both sides so the nation's critical HIV programme can continue.
Broader Implications
This rejection comes after a comparable case in Kenya, where a court suspended a related health funding agreement following legal challenges were filed about the safety of citizens' medical information.
After resuming the presidency recently, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
The agency had administered aid for the American government, but Trump stated its expenditure was "inefficient" and his government was pursuing government-to-government agreements to boost transparency and accountability.
According to reports, 16 nations in Africa have so far signed these new health pacts, representing over $18.3bn in new funding.
Details of the Rejected Agreement
This assistance for Zimbabwe would have supported "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this cooperation would have delivered significant benefits for Zimbabwean communities, particularly the 1.2 million presently on HIV treatment via US-supported initiatives," the Ambassador added.
However, official spokesman Nick Mangwana maintained the arrangement was "unequal".
"The proposal required Zimbabwe to provide its genetic material and health information over an extended period, with no corresponding promise of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," his statement read.
"Put simply, our country would supply the raw materials for medical research without any certainty that the final treatments would be accessible to our citizens if a future pandemic emerge."
Sovereignty and International Frameworks
Mangwana further said that the US's withdrawal from the global health body and its push of one-on-one deals were undermining frameworks previously established via the global organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework created to deal with future pandemics.
"This framework is designed to guarantee that when a country provides its samples, the benefits – such as medicines and cures – are distributed fairly, not commercialised exclusively by those with the funds to develop them."
Zimbabwe's reservations over the US deal "must not be interpreted as hostility towards the US," he added.
"We are open to continued dialogue with our US partners on how subsequent collaboration could be arranged in a manner that respects the independence and dignity of each country."
Health Experts Reaction
A leading public health body stated it acknowledged the government's concerns, but suggested that negotiations need to persist since a large portion of the nation's Aids initiatives were funded by international support.
"If technical issues arise, such as those involving data governance or implementation frameworks, these can often be resolved through technical clarification and mutually agreed protections," it said.
This impasse underscores the ongoing challenges between receiving vital international aid and protecting a country's data in an ever more data-driven world.